Autophagy Is Deficient and May be Negatively Regulated by SERPINB3 in Middle Ear Cholesteatoma.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
23
6
2020
medline:
15
4
2021
entrez:
23
6
2020
Statut:
ppublish
Résumé
Whereas autophagy has been linked to various human diseases, whether it also plays a role in cholesteatoma is virtually unknown. This study aimed to investigate the activity and regulation of autophagy in cholesteatoma. The treatment of middle ear cholesteatoma has been challenging due to an insufficient understanding of the underlying disease mechanism. Expression of microtubule-associated protein 1A/1B-light chain 3 (LC3), the autophagy protein marker, and phosphorylated Akt (p-Akt), and mammalian target of rapamycin (p-mTOR), the known autophagy regulators, in fresh retroauricular skin and cholesteatoma tissue samples was analyzed by immunoblotting. The results were further confirmed by immunohistochemistry and statistical analyses. Cell proliferation of primary retroauricular skin- and cholesteatoma-derived fibroblasts was evaluated by methyl thiazol tetrazolium (MTT) assay. Ectopic expression of serine proteinase inhibitor, clade B, member 3 (SERPINB3) in the fibroblasts was achieved by electroporation and the expression was detected by immunoblotting. LC3 expression was significantly decreased in cholesteatoma in most of the 15 paired retroauricular skin/cholesteatoma tissue samples. However, p-Akt and p-mTOR expression in the cholesteatoma samples was not significantly different from that in the control subjects. Immunohistochemical studies further demonstrated an inverse correlation between LC3 expression and cholesteatoma. The cholesteatoma fibroblasts proliferated faster than the retroauricular skin fibroblasts, and had higher SERPINB3 but lower LC3 expression. Furthermore, overexpression of SERPINB3 in the retroauricular skin fibroblasts enhanced cell proliferation and downregulated LC3 expression. Autophagy is significantly suppressed in cholesteatoma tissues, which may not involve the Akt/mTOR signaling pathway. More importantly, SERPINB3 may promote cell proliferation and negatively regulate autophagy in cholesteatoma fibroblasts. Together, these findings warrant further investigation into the pathogenic mechanism of cholesteatoma.
Sections du résumé
HYPOTHESIS
Whereas autophagy has been linked to various human diseases, whether it also plays a role in cholesteatoma is virtually unknown. This study aimed to investigate the activity and regulation of autophagy in cholesteatoma.
BACKGROUND
The treatment of middle ear cholesteatoma has been challenging due to an insufficient understanding of the underlying disease mechanism.
METHODS
Expression of microtubule-associated protein 1A/1B-light chain 3 (LC3), the autophagy protein marker, and phosphorylated Akt (p-Akt), and mammalian target of rapamycin (p-mTOR), the known autophagy regulators, in fresh retroauricular skin and cholesteatoma tissue samples was analyzed by immunoblotting. The results were further confirmed by immunohistochemistry and statistical analyses. Cell proliferation of primary retroauricular skin- and cholesteatoma-derived fibroblasts was evaluated by methyl thiazol tetrazolium (MTT) assay. Ectopic expression of serine proteinase inhibitor, clade B, member 3 (SERPINB3) in the fibroblasts was achieved by electroporation and the expression was detected by immunoblotting.
RESULTS
LC3 expression was significantly decreased in cholesteatoma in most of the 15 paired retroauricular skin/cholesteatoma tissue samples. However, p-Akt and p-mTOR expression in the cholesteatoma samples was not significantly different from that in the control subjects. Immunohistochemical studies further demonstrated an inverse correlation between LC3 expression and cholesteatoma. The cholesteatoma fibroblasts proliferated faster than the retroauricular skin fibroblasts, and had higher SERPINB3 but lower LC3 expression. Furthermore, overexpression of SERPINB3 in the retroauricular skin fibroblasts enhanced cell proliferation and downregulated LC3 expression.
CONCLUSION
Autophagy is significantly suppressed in cholesteatoma tissues, which may not involve the Akt/mTOR signaling pathway. More importantly, SERPINB3 may promote cell proliferation and negatively regulate autophagy in cholesteatoma fibroblasts. Together, these findings warrant further investigation into the pathogenic mechanism of cholesteatoma.
Identifiants
pubmed: 32569142
doi: 10.1097/MAO.0000000000002690
pii: 00129492-202008000-00037
doi:
Substances chimiques
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e881-e888Références
Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E, Mikaszewski B, Pawełczyk T. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis. ORL J Otorhinolaryngol Relat Spec 2011; 73:93–99.
Haruyam T, Furukawa M, Kusunoki T, Onoda J, Ikeda K. Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma. ORL J Otorhinolaryngol Relat Spec 2010; 72:325–331.
Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E. Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. Am J Otolaryngol 2010; 31:404–409.
Juhn SK, Jung MK, Hoffman MD, et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol 2008; 1:117–138.
Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol 2009; 10:151–160.
Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol 2010; 124:587–593.
Suchozebrska-Jesionek D, Szymański M, Kurzepa J, Gołabek W, tryjecka-Zimmer M. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma. J Otolaryngol Head Neck Surg 2008; 37:628–632.
Maniu A, Harabagiu O, Perde Schrepler M, Catana A, Fanuta B, Mogoanta CA. Molecular biology of cholesteatoma. Rom J Morphol Embryol 2014; 55:7–13.
Shinoda H, Huang CC. Heat shock proteins in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1996; 114:77–83.
Ho KY, Yeh TS, Huang HH, et al. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth. Int J Mol Sci 2013; 14:14439–14459.
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27–42.
Schneider JL, Cuervo AM. Autophagy and human disease: emerging themes. Curr Opin Genet Dev 2014; 26:16–23.
Ho KY, Huang HH, Hung KF, et al. Cholesteatoma growth and proliferation: relevance with Serpin B3. Laryngoscope 2012; 122:2818–2823.
Chiang WF, Hwang TZ, Hour TC, et al. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Oral Oncol 2013; 49:534–541.
Chen JYF, Hour TC, Yang SF, et al. Autophagy is deficient in nasal polyps: implications for the pathogenesis of the disease. Int Forum Allergy Rhinol 2015; 5:119–123.
Chi HP, Ho KY, Chai CY, et al. Epidermal growth factor expression in middle ear cholesteatoma. Kaohsiung J Med Sci 2004; 20:6–11.
Jin BJ, Min HJ, Jeong JH, Park CW, Lee SH. Expression of EGFR and microvessel density in middle ear cholesteatoma. Clin Exp Otohinolaryngol 2011; 4:67–71.
Yune TY, Byun JY. Expression of PTEN and phosphorylated Akt in human cholesteatoma epithelium. Acta Otolaryngol 2009; 129:501–506.
Liu W, Xie S, Chen X, et al. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium. Int J Clin Exp Pathol 2014; 7:709–715.
Helgaland T, Engelen B, Olsnes C, Aarstad HJ, Vassbotn FS. In vitro cholesteatoma growth and secretion of cytokines. Acta Otolaryngol 2010; 130:815–819.
Guzinska-Ustymowicz K, Kurzyna A, Trzpis K, Kemona A, Hassmann-Poznanska E. Keratinocyte growth factor and its receptor in middle-ear cholesteatoma. Otolaryngol Pol 2013; 67:67–71.
Yamamoto-Fukuda T, Akiyama N, Shibata Y, Takahashi H, Ikeda T, Koji T. In vivo over-expression of KGF mimic human middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2015; 272:2689–2696.
Baysal E, Aksoy N, Kara F, et al. Oxidative stress in chronic otitis media. Eur Arch Otorhinolaryngol 2013; 270:1203–1208.
Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 2009; 16:46–56.
Ho KY, Huang HH, Hung KF, et al. Cholesteatoma growth and proliferation: relevance with serpin B3. Laryngoscope 2012; 122:2818–2823.
Tokuriki M, Noda I, Saito T, et al. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays. Laryngoscope 2003; 113:808–814.
Vidalino L, Doria A, Quarta S, Zen M, Gatta A, Pontisso P. SERPINB3, apoptosis and autoimmunity. Autoimmun Rev 2009; 9:108–112.
Ciscato F, Sciacovelli M, Villano G, et al. SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. Oncotarget 2014; 5:2418–2427.
Vidalino L, Doria A, Quarta SM, et al. SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection. Exp Biol Med 2012; 237:793–802.
Iversen OJ, Lysvand H, Slupphaug G. Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases. Clin Immunol 2017; 174:10–17.
Cannito S, Turato C, Paternostro C. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. Oncotarget 2015; 6:2206–2221.
Terrin L, Agostini M, Ruvoletto M. SerpinB3 upregulates the Cyclooxygenase-2/β-Catenin positive loop in colorectal cancer. Oncotarget 2017; 8:15732–15743.
Collie-Duguid ES, Sweeney K, Stewart KN, Miller ID, Smyth E, Heys SD. SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 2012; 132:807–818.
Quarta S, Vidalino L, Turato C. SERPINB3 induces epithelial-mesenchymal transition. J Pathol 2010; 221:343–356.
Sheshadri N, Catanzaro JM, Bott AJ, et al. SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL-6 signaling. Cancer Res 2014; 74:6318–6329.
Guo W, Chen Z, Chen Z, et al. Promotion of cell proliferation through Inhibition of cell autophagy signalling pathway by Rab3IP is restrained by microRNA-532-3p in gastric cancer. J Cancer 2018; 9:4363–4373.
Shi Y, Zhao Y, Shao N, et al. Overexpression of microRNA-96-5p inhibits autophagy and apoptosis and enhances the proliferation, migration and invasiveness of human breast cancer cells. Oncol Lett 2017; 13:4402–4412.
Wang H, Wang Y, Qian L. RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy. Oncotarget 2016; 7:51174–51183.
Hsu KF, Wu CL, Huang SC. Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy 2009; 5:451–460.
Wei DH, Jia XY, Liu YH. Cathepsin L stimulates autophagy and inhibits apoptosis of ox-LDL-induced endothelial cells: potential role in atherosclerosis. Int J Mol Med 2013; 31:400–406.